Sbi Securities Co., Ltd. Spero Therapeutics, Inc. Transaction History
Sbi Securities Co., Ltd.
- $3.48 Trillion
- Q2 2025
A detailed history of Sbi Securities Co., Ltd. transactions in Spero Therapeutics, Inc. stock. As of the latest transaction made, Sbi Securities Co., Ltd. holds 62 shares of SPRO stock, worth $145. This represents 0.0% of its overall portfolio holdings.
Number of Shares
62
Previous 60
3.33%
Holding current value
$145
Previous $43,000
318.6%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding SPRO
# of Institutions
50Shares Held
10.5MCall Options Held
0Put Options Held
186K-
Vanguard Group Inc Valley Forge, PA1.95MShares$4.58 Million0.0% of portfolio
-
Anson Funds Management LP Dallas, TX1.62MShares$3.8 Million0.86% of portfolio
-
Atlas Venture Associates Ix, LLC Boston, MA1.35MShares$3.18 Million14.54% of portfolio
-
Alphabet Inc. Mountain View, CA890KShares$2.09 Million0.17% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny832KShares$1.96 Million0.0% of portfolio
About Spero Therapeutics, Inc.
- Ticker SPRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,067,500
- Market Cap $82.4M
- Description
- Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to ...